Takeda Pharmaceutical Co. Ltd. reported its share repurchase activities for March 2025, highlighting the buyback of 6,148,200 shares totaling approximately JPY 27.2 billion. As of March 31, 2025, 11,543,600 shares have been repurchased, achieving 40.5% of their target under a plan approved in January 2025.